Here are six quick facts:
1. Eight analysts rated the stock a “buy,” nine rated the stock an “outperform” and seven rated the stock a “hold.”
2. The 24 analysts gave an estimate of $1.46 per share for this quarter.
3. The analysts gave a high estimate of $1.68 and a low estimate of $0.98.
4. The company’s revenue is expected to hit $10.22 billion.
5. The analysts forecasted HCA would report earnings of $6.25 per share, for the full year.
6. HCA is expected to maintain an annual growth rate of 10.87 percent for the next five years.
More articles on transactions & valuation:
9 new outpatient surgery centers in February 2016
HCA to open provider-based ER in Las Vegas: 6 things to know
SCA Director sells 11k shares — 5 notes
